1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ADAPTIVE BIOTECHNOLOGIES CORP
Adaptive Biotechnologies Corp XNAS: ADPT
19.72 -0.60 (-2.95%)
1.9M
XNAS Volume

XNAS 26 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

Insider Trade
Sharon Benzeno, CCO & 10% owner of Adaptive Biotechnologies, sells 606K shares worth $10.1 million See details

Adaptive Biotechnologies Corp - ADPT - stock price prediction, stock price target, analyst ratings from 8 analysts

Adaptive Biotechnologies Corp has a share price target of US$ 20, revenue growth forecast of 47.9%, and profit growth estimate of 53.0% for FY25, based on top 8 analyst calls.